beta-solamarine has been researched along with Carcinoma, Hepatocellular in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Han, L; Li, X; Long, S; Sheng, H; Tang, Q; Wang, S; Wu, W; Yu, Y | 1 |
Fu, L; Jin, W; Qiu, Y; Wang, T; Yin, S; Yu, H | 1 |
Kalalinia, F; Marashi, SH; Sani, IK | 1 |
Ding, X; Gao, SG; Li, M; Zhu, FS | 1 |
Hsu, SH; Kuo, KW; Lin, CN; Tsai, TR; Yen, MH | 1 |
Chang, LC; Kuo, KW; Lin, CN; Tsai, TR; Wang, JJ | 1 |
Chang, LC; Hsu, SH; Kuo, KW; Li, YP; Lin, CC; Lin, CN; Lin, WL; Liu, LF; Sheu, HM | 1 |
7 other study(ies) available for beta-solamarine and Carcinoma, Hepatocellular
Article | Year |
---|---|
Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP-TUG1/miR-4726-5p/MUC1 pathway.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Mucin-1; RNA, Long Noncoding; Solanaceous Alkaloids; Sorafenib | 2022 |
Solamargine induces hepatocellular carcinoma cell apoptosis and autophagy via inhibiting LIF/miR-192-5p/CYR61/Akt signaling pathways and eliciting immunostimulatory tumor microenvironment.
Topics: Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Proto-Oncogene Proteins c-akt; Signal Transduction; Solanaceous Alkaloids; Tumor Microenvironment | 2022 |
Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Movement; Down-Regulation; Hep G2 Cells; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Solanaceous Alkaloids | 2015 |
Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Proliferation; Cell Shape; Cell Survival; Colorimetry; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Microscopy, Fluorescence; Plant Extracts; Plants, Medicinal; Solanaceous Alkaloids; Solanum nigrum; Up-Regulation | 2012 |
Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis.
Topics: Antigens, CD; Apoptosis; Carcinoma, Hepatocellular; Cells, Cultured; Drugs, Chinese Herbal; Fibroblasts; Gene Expression; Humans; Phytosterols; Plants, Medicinal; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Skin; Solanaceous Alkaloids | 1996 |
The rhamnose moiety of solamargine plays a crucial role in triggering cell death by apoptosis.
Topics: Antigens, CD; Apoptosis; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Molecular Conformation; Phytosterols; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Rhamnose; Solanaceous Alkaloids; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |
Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells.
Topics: Antibodies; Antigens, CD; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Survival; DNA, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression; Humans; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Solanaceous Alkaloids; Tumor Cells, Cultured | 2000 |